Thor Medical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jasper Kurth
Chief executive officer
NOK 3.6m
Total compensation
| CEO salary percentage | 31.83% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | NOK 4m | NOK 1m | -NOK 42m |
Compensation vs Market: Jasper's total compensation ($USD350.40K) is about average for companies of similar size in the UK market ($USD377.90K).
Compensation vs Earnings: Insufficient data to compare Jasper's compensation with company performance.
CEO
Jasper Kurth (39 yo)
less than a year
Tenure
NOK 3,644,000
Compensation
Mr. Jasper Kurth is Chief Executive Officer of Thor Medical ASA from August 1, 2024. Mr. Jasper Kurth joined Thor Medical from several positions at Bayer Pharmaceuticals, most recently as General Manager R...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | NOK 3.64m | no data | |
| Chief Financial & Operating Officer | 1.8yrs | NOK 2.66m | no data | |
| Chief Technology Officer | 1.9yrs | NOK 2.77m | 0.025% NOK 208.4k | |
| Executive VP of Business Development & Strategic Advisor | less than a year | NOK 1.80m | 0.14% NOK 1.2m | |
| Executive VP of HSEQ | less than a year | NOK 2.35m | no data | |
| Vice President of Communications | no data | no data | no data |
0.8yrs
Average Tenure
Experienced Management: 0R6Y's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 18:34 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Thor Medical ASA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.